NL7301975A - - Google Patents

Info

Publication number
NL7301975A
NL7301975A NL7301975A NL7301975A NL7301975A NL 7301975 A NL7301975 A NL 7301975A NL 7301975 A NL7301975 A NL 7301975A NL 7301975 A NL7301975 A NL 7301975A NL 7301975 A NL7301975 A NL 7301975A
Authority
NL
Netherlands
Application number
NL7301975A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7301975A publication Critical patent/NL7301975A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
NL7301975A 1972-02-11 1973-02-12 NL7301975A (cg-RX-API-DMAC7.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2207420A DE2207420A1 (de) 1972-02-11 1972-02-11 Verfahren zur herstellung von 16,17ungesaettigten steroiden

Publications (1)

Publication Number Publication Date
NL7301975A true NL7301975A (cg-RX-API-DMAC7.html) 1973-08-14

Family

ID=5836210

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7301975A NL7301975A (cg-RX-API-DMAC7.html) 1972-02-11 1973-02-12

Country Status (15)

Country Link
US (1) US3842105A (cg-RX-API-DMAC7.html)
JP (1) JPS4886854A (cg-RX-API-DMAC7.html)
AT (1) AT328102B (cg-RX-API-DMAC7.html)
AU (1) AU468856B2 (cg-RX-API-DMAC7.html)
BE (1) BE795243A (cg-RX-API-DMAC7.html)
CH (1) CH586719A5 (cg-RX-API-DMAC7.html)
CS (1) CS165381B2 (cg-RX-API-DMAC7.html)
DD (1) DD100942A5 (cg-RX-API-DMAC7.html)
DE (1) DE2207420A1 (cg-RX-API-DMAC7.html)
DK (1) DK131942C (cg-RX-API-DMAC7.html)
FR (1) FR2171374B1 (cg-RX-API-DMAC7.html)
GB (1) GB1424212A (cg-RX-API-DMAC7.html)
HU (1) HU165442B (cg-RX-API-DMAC7.html)
NL (1) NL7301975A (cg-RX-API-DMAC7.html)
SE (1) SE385591B (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4216159A (en) * 1978-05-25 1980-08-05 The Upjohn Company Synthesis of 16-unsaturated pregnanes from 17-keto steroids
US5169966A (en) * 1987-09-11 1992-12-08 Nippon Zeon Co., Ltd Process for producing an α-acyloxy-α, β-unsaturated carbonyl compound and a 20-acyloxy-17(20)-methylen-21-al-steroid compound
DE3852252T2 (de) * 1987-09-11 1995-04-06 Nippon Zeon Co Verfahren zur Herstellung einer alpha-acyloxy-alpha-beta-ungesättigten Verbindung und eines 20-acyloxy-17(20)-methylen-21-al-steroidderivats.
EP2278978B1 (en) * 2008-05-28 2015-09-02 ReveraGen BioPharma, Inc. Non-hormonal steroid modulators of nf-kb for treatment of disease
US9198921B2 (en) 2010-04-05 2015-12-01 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-κB for treatment of disease
CN102603843B (zh) * 2012-02-20 2013-07-31 湖南诺凯生物医药有限公司 一种地塞米松中间体的制备方法
US10799514B2 (en) 2015-06-29 2020-10-13 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kappa beta for treatment of disease
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Also Published As

Publication number Publication date
DK131942C (da) 1976-02-23
JPS4886854A (cg-RX-API-DMAC7.html) 1973-11-15
AU468856B2 (en) 1976-01-22
AT328102B (de) 1976-03-10
DE2207420A1 (de) 1973-08-16
DK131942B (da) 1975-09-29
ATA112373A (de) 1975-05-15
CS165381B2 (cg-RX-API-DMAC7.html) 1975-12-22
FR2171374A1 (cg-RX-API-DMAC7.html) 1973-09-21
SE385591B (sv) 1976-07-12
FR2171374B1 (cg-RX-API-DMAC7.html) 1976-06-11
AU5193173A (en) 1974-08-08
DD100942A5 (cg-RX-API-DMAC7.html) 1973-10-12
HU165442B (cg-RX-API-DMAC7.html) 1974-08-28
GB1424212A (en) 1976-02-11
US3842105A (en) 1974-10-15
CH586719A5 (cg-RX-API-DMAC7.html) 1977-04-15
BE795243A (fr) 1973-08-09

Similar Documents

Publication Publication Date Title
FR2171374A1 (cg-RX-API-DMAC7.html)
CS152931B1 (cg-RX-API-DMAC7.html)
CS153297B1 (cg-RX-API-DMAC7.html)
CS153933B1 (cg-RX-API-DMAC7.html)
CS154095B1 (cg-RX-API-DMAC7.html)
CS155000B1 (cg-RX-API-DMAC7.html)
CS154828B1 (cg-RX-API-DMAC7.html)
CS154134B1 (cg-RX-API-DMAC7.html)
CH569465A5 (cg-RX-API-DMAC7.html)
CH571802A5 (cg-RX-API-DMAC7.html)
CH560331A5 (cg-RX-API-DMAC7.html)
CH560773A5 (cg-RX-API-DMAC7.html)
CH561395A5 (cg-RX-API-DMAC7.html)
CH577423A5 (cg-RX-API-DMAC7.html)
CH562332A5 (cg-RX-API-DMAC7.html)
CH562883A (cg-RX-API-DMAC7.html)
CH562985A5 (cg-RX-API-DMAC7.html)
CH563044A5 (cg-RX-API-DMAC7.html)
CH564259A5 (cg-RX-API-DMAC7.html)
CH564752A5 (cg-RX-API-DMAC7.html)
CH566234A5 (cg-RX-API-DMAC7.html)
CH566717A5 (cg-RX-API-DMAC7.html)
CH567359A5 (cg-RX-API-DMAC7.html)
CH567383A5 (cg-RX-API-DMAC7.html)
CH559034A5 (cg-RX-API-DMAC7.html)

Legal Events

Date Code Title Description
BV The patent application has lapsed